Like semaglutide, Tirzepitide is a GLP-1 receptor agonist but with an additional mechanism of action it also targets the GIP (glucose-dependent insulinotropic polypeptide) receptor
A compound that does nothing harmful but also does very little beneficial is not necessarily a superior choice for someone who needs significant weight loss
Please consult with us if you are pregnant or plan to become pregnant within the next two months, if you are a minor, or if you are over 60 years old
However, the topic appears to contain some interesting associations that require further research
00:15:36 Vickie Danaher For example, orforglipron may be better for patients who want or need simpler or more flexible dosing, or those who struggle with fasting requirements or morning routines, since it can be taken at any time of day with or without food
Existing Human Pilot Data (20212025) Three published human pilot studies as of July 2026 all small, uncontrolled, but directionally consistent